Gilead buys Kite Pharma for $11.9bn
- Gene Therapy, Cell Therapy
- Large Molecule
- Intra-Biotech Deal
- Payment Includes Cash
- Includes Contract
- Full Acquisition
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.